Form 8-K - Current report:
SEC Accession No. 0001599901-25-000134
Filing Date
2025-07-23
Accepted
2025-07-23 16:46:24
Documents
12
Period of Report
2025-07-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rna-20250723.htm   iXBRL 8-K 31163
  Complete submission text file 0001599901-25-000134.txt   150896

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20250723.xsd EX-101.SCH 1812
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20250723_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20250723_pre.xml EX-101.PRE 13067
14 EXTRACTED XBRL INSTANCE DOCUMENT rna-20250723_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 251143628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)